554 related articles for article (PubMed ID: 27612551)
1. Cardiovascular disease in patients with rheumatoid arthritis.
Liao KP
Trends Cardiovasc Med; 2017 Feb; 27(2):136-140. PubMed ID: 27612551
[TBL] [Abstract][Full Text] [Related]
2. Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases.
Mackey RH; Kuller LH; Moreland LW
Rheum Dis Clin North Am; 2018 Aug; 44(3):475-487. PubMed ID: 30001787
[TBL] [Abstract][Full Text] [Related]
3. Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.
Nowak B; Madej M; Łuczak A; Małecki R; Wiland P
Adv Clin Exp Med; 2016; 25(1):43-50. PubMed ID: 26935497
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis.
López-Mejías R; Corrales A; Genre F; Hernández JL; Ochoa R; Blanco R; González-Juanatey C; Martín J; Llorca J; González-Gay MA
Clin Exp Rheumatol; 2013; 31(5):761-6. PubMed ID: 23899926
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers.
López-Mejías R; Castañeda S; González-Juanatey C; Corrales A; Ferraz-Amaro I; Genre F; Remuzgo-Martínez S; Rodriguez-Rodriguez L; Blanco R; Llorca J; Martín J; González-Gay MA
Autoimmun Rev; 2016 Nov; 15(11):1013-1030. PubMed ID: 27490206
[TBL] [Abstract][Full Text] [Related]
6. Red cell distribution width is associated with endothelial progenitor cell depletion and vascular-related mediators in rheumatoid arthritis.
Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Carro-Esteban SR; Ballina-García FJ; Suárez A
Atherosclerosis; 2015 May; 240(1):131-6. PubMed ID: 25778627
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
Jurcuţ C; Jurcuţ R; Tănăsescu C
Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis.
Halacoglu J; Shea LA
J Cardiovasc Transl Res; 2020 Oct; 13(5):878-890. PubMed ID: 32080804
[TBL] [Abstract][Full Text] [Related]
9. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cardiovascular disease in rheumatoid arthritis.
Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.
Lazúrová I; Tomáš Ľ
Clin Rev Allergy Immunol; 2017 Jun; 52(3):323-332. PubMed ID: 27342458
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease in rheumatoid arthritis.
Sen D; González-Mayda M; Brasington RD
Rheum Dis Clin North Am; 2014 Feb; 40(1):27-49. PubMed ID: 24268008
[TBL] [Abstract][Full Text] [Related]
13. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.
Myasoedova E; Crowson CS; Kremers HM; Roger VL; Fitz-Gibbon PD; Therneau TM; Gabriel SE
Ann Rheum Dis; 2011 Mar; 70(3):482-7. PubMed ID: 21216812
[TBL] [Abstract][Full Text] [Related]
14. [Inflammation-related cardiovascular morbidity : Pathophysiology and therapy].
Fischer-Betz R; Halle M; Schneider M
Z Rheumatol; 2010 Oct; 69(8):680-4, 686-8. PubMed ID: 20862480
[TBL] [Abstract][Full Text] [Related]
15. The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis.
Peters MJ; van Sijl AM; Voskuyl AE; Sattar N; Smulders YM; Nurmohamed MT
Curr Pharm Des; 2012; 18(11):1502-11. PubMed ID: 22364134
[TBL] [Abstract][Full Text] [Related]
16. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
17. [Increased cardiovascular risk and premature atherosclerosis in rheumatoid arthritis].
Akrout R; Fourati H; Mnif E; Ben Mahfoudh KH; Hachicha I; Ezzeddine M; Ayédi F; Mnif J; Baklouti S
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):267-73. PubMed ID: 22794936
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.
van den Oever IAM; Heslinga M; Griep EN; Griep-Wentink HRM; Schotsman R; Cambach W; Dijkmans BAC; Smulders YM; Lems WF; Boers M; Voskuyl AE; Peters MJL; van Schaardenburg D; Nurmohamed MT
Rheumatology (Oxford); 2017 Sep; 56(9):1472-1478. PubMed ID: 28199724
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular diseases and rheumatoid arthritis].
Morović-Vergles J
Reumatizam; 2010; 57(2):11-5. PubMed ID: 21874999
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
Giollo A; Bissell LA; Buch MH
Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
